China is pumping money into its biotech industry, helping launch a new wave of labs and incubators in the country. Experts say this could slow down American innovation in the biotech space. China's ...

For decades, America has led the global biotech industry – thanks, in part, to state-level policies that encourage research and manufacturing investments.

Biotechnology is no longer distant science fiction; it’s already a growing force in both national security and local economies. It affects everything from how much you pay at the pharmacy to whether ...

In 2025, fewer biotech deals are getting done, but the dollars behind them are bigger than ever. Having spent years working with emerging and fast-growth life sciences companies, I’ve seen firsthand ...

Virginia is making strides in biotechnology with the launch of Project Vital. Project Vital is a statewide initiative to invest in research, workforce development, and biotech startups, positioning ...

China’s biotech sector is surging. For the first time, it now leads the world in clinical trials and new drug licensing. The U.S., once the undisputed leader in pharmaceutical innovation, risks losing ...

At this year’s Biotech Week, Terri Clevenger, Head of Integrated Communications at Waterhouse Brands, emphasized the growing importance of reputation in biotech deal-making amid a turbulent 2025. In ...

In the fast-paced world of biotechnology, success hinges on more than groundbreaking science—it requires the right connections, strategic partnerships, and access to capital. Biotech Showcase delivers ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...

Enhertu is also the same general type of drug that Fields worked on for a decade at Seagen, a Bothell-based biotech that sold to Pfizer in 2023 for $43 billion. Two of the Seagen drugs she worked on, ...